Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin

Abdur Rauf1, Tareq Abu-Izneid2, Muhammad Imran3

  • 1Department of Chemistry, University of Swabi, Anbar, KPK, Pakistan.

Insights

Fisetin, a natural flavonoid from fruits and vegetables, shows promise in cancer prevention and treatment by targeting cancer cells. Further human clinical trials are needed to confirm its broad effectiveness against various cancers.

Area of Science:

  • Dietary compounds
  • Natural products pharmacology
  • Oncology

Background:

  • Flavonoids exhibit therapeutic potential for cancer, inflammation, and oxidative stress.
  • Fisetin, a plant-derived flavonoid, demonstrates anti-cancer properties by influencing cell cycle and angiogenesis.
  • Cancer remains a leading global cause of mortality, necessitating novel therapeutic strategies.

Approach:

  • This review synthesizes current research on fisetin's molecular functions and pharmacological activities.
  • Focuses on fisetin's efficacy in preclinical models against various chronic conditions, including cancer, metabolic, and neurological disorders.
  • Highlights the potential of fisetin as a dietary component for disease prevention and treatment.

Key Points:

  • Fisetin effectively suppresses cancer cell proliferation and angiogenesis without harming healthy cells.
  • The compound exhibits broad pharmacological activities, including potential applications in diabetes, obesity, allergies, and neurological conditions.
  • Research underscores fisetin's role in combating chronic diseases through its molecular mechanisms.

Conclusions:

  • Fisetin holds significant potential for cancer prevention and treatment due to its targeted anti-cancer effects.
  • Further clinical investigations in humans are warranted to validate fisetin's efficacy across diverse cancer types.
  • Fisetin's multifaceted pharmacological activities suggest its utility in managing a spectrum of chronic diseases.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K